Laminin γ2 fragments are increased in the circulation of patients with early phase acute lung injury

Masahiko Katayama, Akitoshi Ishizaka, Michiie Sakamoto, Seitaro Fujishima, Kiyotoshi Sekiguchi, Koichiro Asano, Tomoko Betsuyaku, Toru Kotani, Lorraine B. Ware, Michael A. Matthay, Satoru Hashimoto

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Objective: Laminin-5, a cell adhesive molecule expressed solely by epithelium, is known to enhance epithelial cell migration and repair of injured epithelium, after its essential component γ2-chain is processed proteolytically. Our previous study revealed circulating levels of amino-terminal fragment of laminin γ2-chain (G2F) reflect epithelial tumor invasiveness in carcinoma patients, but its physiological role in alveolar epithelial injury remains unknown. Design: Sampling of epithelial lining fluids or pulmonary edema fluids from patients with acute lung injury (ALI) or related diseases was performed. Plasma samples were obtained from them at the time of disease onset or later. G2F concentrations were determined by immunoassay constructed by ourselves. Results: We found a significantly higher amount of G2F in pulmonary edema and epithelial lining fluids of patients with ALI, as compared with those with the other respiratory diseases. Their plasma levels were also elevated significantly early at the onset of ALI (mean ± SD; 147 ± 82 ng/ml in non-surviving and 90 ± 56 in surviving patients) as compared with those in the patients with cardiogenic pulmonary edema (59 ± 36) or idiopathic pulmonary fibrosis (37 ± 17), indicating alveolar epithelium rapidly secrete laminin-5 in ALI. At 5 days after onset, non-surviving patients maintained higher plasma concentrations (152 ± 84), but in contrast, the levels in surviving patients declined (71 ± 35), suggesting secretion of laminin-5 was suppressed, associated with recovery from ALI. Conclusion: Circulating G2F may be a biomarker for alveolar laminin-5 secreted early at disease onset in ALI, potentially regulating alveolar re-epithelialization.

Original languageEnglish
Pages (from-to)479-486
Number of pages8
JournalIntensive Care Medicine
Volume36
Issue number3
DOIs
Publication statusPublished - 2010 Mar

Fingerprint

Acute Lung Injury
Laminin
Pulmonary Edema
Epithelium
Re-Epithelialization
Idiopathic Pulmonary Fibrosis
Immunoassay
Adhesives
Cell Movement
Biomarkers
Epithelial Cells
Carcinoma
kalinin
Wounds and Injuries
Neoplasms

Keywords

  • Acute lung injury
  • Alveolar epithelial repair
  • Circulation
  • Laminin

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this

Laminin γ2 fragments are increased in the circulation of patients with early phase acute lung injury. / Katayama, Masahiko; Ishizaka, Akitoshi; Sakamoto, Michiie; Fujishima, Seitaro; Sekiguchi, Kiyotoshi; Asano, Koichiro; Betsuyaku, Tomoko; Kotani, Toru; Ware, Lorraine B.; Matthay, Michael A.; Hashimoto, Satoru.

In: Intensive Care Medicine, Vol. 36, No. 3, 03.2010, p. 479-486.

Research output: Contribution to journalArticle

Katayama, M, Ishizaka, A, Sakamoto, M, Fujishima, S, Sekiguchi, K, Asano, K, Betsuyaku, T, Kotani, T, Ware, LB, Matthay, MA & Hashimoto, S 2010, 'Laminin γ2 fragments are increased in the circulation of patients with early phase acute lung injury', Intensive Care Medicine, vol. 36, no. 3, pp. 479-486. https://doi.org/10.1007/s00134-009-1719-6
Katayama, Masahiko ; Ishizaka, Akitoshi ; Sakamoto, Michiie ; Fujishima, Seitaro ; Sekiguchi, Kiyotoshi ; Asano, Koichiro ; Betsuyaku, Tomoko ; Kotani, Toru ; Ware, Lorraine B. ; Matthay, Michael A. ; Hashimoto, Satoru. / Laminin γ2 fragments are increased in the circulation of patients with early phase acute lung injury. In: Intensive Care Medicine. 2010 ; Vol. 36, No. 3. pp. 479-486.
@article{1812ffce266c4fbdb6f368ed54144f8d,
title = "Laminin γ2 fragments are increased in the circulation of patients with early phase acute lung injury",
abstract = "Objective: Laminin-5, a cell adhesive molecule expressed solely by epithelium, is known to enhance epithelial cell migration and repair of injured epithelium, after its essential component γ2-chain is processed proteolytically. Our previous study revealed circulating levels of amino-terminal fragment of laminin γ2-chain (G2F) reflect epithelial tumor invasiveness in carcinoma patients, but its physiological role in alveolar epithelial injury remains unknown. Design: Sampling of epithelial lining fluids or pulmonary edema fluids from patients with acute lung injury (ALI) or related diseases was performed. Plasma samples were obtained from them at the time of disease onset or later. G2F concentrations were determined by immunoassay constructed by ourselves. Results: We found a significantly higher amount of G2F in pulmonary edema and epithelial lining fluids of patients with ALI, as compared with those with the other respiratory diseases. Their plasma levels were also elevated significantly early at the onset of ALI (mean ± SD; 147 ± 82 ng/ml in non-surviving and 90 ± 56 in surviving patients) as compared with those in the patients with cardiogenic pulmonary edema (59 ± 36) or idiopathic pulmonary fibrosis (37 ± 17), indicating alveolar epithelium rapidly secrete laminin-5 in ALI. At 5 days after onset, non-surviving patients maintained higher plasma concentrations (152 ± 84), but in contrast, the levels in surviving patients declined (71 ± 35), suggesting secretion of laminin-5 was suppressed, associated with recovery from ALI. Conclusion: Circulating G2F may be a biomarker for alveolar laminin-5 secreted early at disease onset in ALI, potentially regulating alveolar re-epithelialization.",
keywords = "Acute lung injury, Alveolar epithelial repair, Circulation, Laminin",
author = "Masahiko Katayama and Akitoshi Ishizaka and Michiie Sakamoto and Seitaro Fujishima and Kiyotoshi Sekiguchi and Koichiro Asano and Tomoko Betsuyaku and Toru Kotani and Ware, {Lorraine B.} and Matthay, {Michael A.} and Satoru Hashimoto",
year = "2010",
month = "3",
doi = "10.1007/s00134-009-1719-6",
language = "English",
volume = "36",
pages = "479--486",
journal = "Intensive Care Medicine",
issn = "0342-4642",
publisher = "Springer Verlag",
number = "3",

}

TY - JOUR

T1 - Laminin γ2 fragments are increased in the circulation of patients with early phase acute lung injury

AU - Katayama, Masahiko

AU - Ishizaka, Akitoshi

AU - Sakamoto, Michiie

AU - Fujishima, Seitaro

AU - Sekiguchi, Kiyotoshi

AU - Asano, Koichiro

AU - Betsuyaku, Tomoko

AU - Kotani, Toru

AU - Ware, Lorraine B.

AU - Matthay, Michael A.

AU - Hashimoto, Satoru

PY - 2010/3

Y1 - 2010/3

N2 - Objective: Laminin-5, a cell adhesive molecule expressed solely by epithelium, is known to enhance epithelial cell migration and repair of injured epithelium, after its essential component γ2-chain is processed proteolytically. Our previous study revealed circulating levels of amino-terminal fragment of laminin γ2-chain (G2F) reflect epithelial tumor invasiveness in carcinoma patients, but its physiological role in alveolar epithelial injury remains unknown. Design: Sampling of epithelial lining fluids or pulmonary edema fluids from patients with acute lung injury (ALI) or related diseases was performed. Plasma samples were obtained from them at the time of disease onset or later. G2F concentrations were determined by immunoassay constructed by ourselves. Results: We found a significantly higher amount of G2F in pulmonary edema and epithelial lining fluids of patients with ALI, as compared with those with the other respiratory diseases. Their plasma levels were also elevated significantly early at the onset of ALI (mean ± SD; 147 ± 82 ng/ml in non-surviving and 90 ± 56 in surviving patients) as compared with those in the patients with cardiogenic pulmonary edema (59 ± 36) or idiopathic pulmonary fibrosis (37 ± 17), indicating alveolar epithelium rapidly secrete laminin-5 in ALI. At 5 days after onset, non-surviving patients maintained higher plasma concentrations (152 ± 84), but in contrast, the levels in surviving patients declined (71 ± 35), suggesting secretion of laminin-5 was suppressed, associated with recovery from ALI. Conclusion: Circulating G2F may be a biomarker for alveolar laminin-5 secreted early at disease onset in ALI, potentially regulating alveolar re-epithelialization.

AB - Objective: Laminin-5, a cell adhesive molecule expressed solely by epithelium, is known to enhance epithelial cell migration and repair of injured epithelium, after its essential component γ2-chain is processed proteolytically. Our previous study revealed circulating levels of amino-terminal fragment of laminin γ2-chain (G2F) reflect epithelial tumor invasiveness in carcinoma patients, but its physiological role in alveolar epithelial injury remains unknown. Design: Sampling of epithelial lining fluids or pulmonary edema fluids from patients with acute lung injury (ALI) or related diseases was performed. Plasma samples were obtained from them at the time of disease onset or later. G2F concentrations were determined by immunoassay constructed by ourselves. Results: We found a significantly higher amount of G2F in pulmonary edema and epithelial lining fluids of patients with ALI, as compared with those with the other respiratory diseases. Their plasma levels were also elevated significantly early at the onset of ALI (mean ± SD; 147 ± 82 ng/ml in non-surviving and 90 ± 56 in surviving patients) as compared with those in the patients with cardiogenic pulmonary edema (59 ± 36) or idiopathic pulmonary fibrosis (37 ± 17), indicating alveolar epithelium rapidly secrete laminin-5 in ALI. At 5 days after onset, non-surviving patients maintained higher plasma concentrations (152 ± 84), but in contrast, the levels in surviving patients declined (71 ± 35), suggesting secretion of laminin-5 was suppressed, associated with recovery from ALI. Conclusion: Circulating G2F may be a biomarker for alveolar laminin-5 secreted early at disease onset in ALI, potentially regulating alveolar re-epithelialization.

KW - Acute lung injury

KW - Alveolar epithelial repair

KW - Circulation

KW - Laminin

UR - http://www.scopus.com/inward/record.url?scp=77951205465&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951205465&partnerID=8YFLogxK

U2 - 10.1007/s00134-009-1719-6

DO - 10.1007/s00134-009-1719-6

M3 - Article

C2 - 19940975

AN - SCOPUS:77951205465

VL - 36

SP - 479

EP - 486

JO - Intensive Care Medicine

JF - Intensive Care Medicine

SN - 0342-4642

IS - 3

ER -